Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 4
1946 1
1947 2
1948 2
1949 1
1950 3
1951 1
1952 3
1953 2
1954 2
1955 1
1956 1
1957 2
1958 2
1959 7
1960 1
1961 1
1962 2
1963 1
1964 3
1965 5
1966 1
1967 1
1969 1
1970 1
1971 1
1972 1
1973 3
1974 1
1975 4
1976 6
1977 4
1978 5
1979 5
1980 8
1981 10
1982 7
1983 9
1984 12
1985 13
1986 19
1987 16
1988 10
1989 29
1990 11
1991 14
1992 17
1993 34
1994 53
1995 26
1996 35
1997 30
1998 47
1999 51
2000 44
2001 58
2002 69
2003 81
2004 98
2005 150
2006 134
2007 150
2008 162
2009 189
2010 217
2011 191
2012 240
2013 336
2014 354
2015 417
2016 392
2017 431
2018 481
2019 583
2020 706
2021 794
2022 890
2023 883
2024 980
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,679 results

Results by year

Filters applied: . Clear all
Page 1
Engineered pegRNAs improve prime editing efficiency.
Nelson JW, Randolph PB, Shen SP, Everette KA, Chen PJ, Anzalone AV, An M, Newby GA, Chen JC, Hsu A, Liu DR. Nelson JW, et al. Among authors: shen sp. Nat Biotechnol. 2022 Mar;40(3):402-410. doi: 10.1038/s41587-021-01039-7. Epub 2021 Oct 4. Nat Biotechnol. 2022. PMID: 34608327 Free PMC article.
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
Zhang L, Zhang Y, Shen S, Wang X, Dong L, Li Q, Ren W, Li Y, Bai J, Gong Q, Kuang H, Qi L, Lu Q, Cheng W, Liu Y, Yan S, Wu D, Fang H, Hou F, Wang Y, Yang Z, Lian X, Du J, Sun N, Ji L, Li G; China Diabetes Prevention Program Study Group. Zhang L, et al. Among authors: shen s. Lancet Diabetes Endocrinol. 2023 Aug;11(8):567-577. doi: 10.1016/S2213-8587(23)00132-8. Epub 2023 Jul 3. Lancet Diabetes Endocrinol. 2023. PMID: 37414069 Clinical Trial.
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy.
Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, Zhang Y, Shen S, Tong N. Lu X, et al. Among authors: shen s. Signal Transduct Target Ther. 2024 Oct 2;9(1):262. doi: 10.1038/s41392-024-01951-9. Signal Transduct Target Ther. 2024. PMID: 39353925 Free PMC article. Review.
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
Li N, Tan F, Chen W, Dai M, Wang F, Shen S, Tang W, Li J, Yu Y, Cao W, Xu Y, Qin C, Zhao L, Zhu M, Guo L, Wu Z, Yang Z, Zheng Y, Chen H, Liu Y, Wei D, Dong D, Cao J, Zhang S, Yan S, Wang N, Du L, Shen H, Wu N, He J; National Lung Cancer Screening programme group. Li N, et al. Among authors: shen s. Lancet Respir Med. 2022 Apr;10(4):378-391. doi: 10.1016/S2213-2600(21)00560-9. Epub 2022 Mar 8. Lancet Respir Med. 2022. PMID: 35276087
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities.
Russo M, Chen M, Mariella E, Peng H, Rehman SK, Sancho E, Sogari A, Toh TS, Balaban NQ, Batlle E, Bernards R, Garnett MJ, Hangauer M, Leucci E, Marine JC, O'Brien CA, Oren Y, Patton EE, Robert C, Rosenberg SM, Shen S, Bardelli A. Russo M, et al. Among authors: shen s. Nat Rev Cancer. 2024 Oct;24(10):694-717. doi: 10.1038/s41568-024-00737-z. Epub 2024 Sep 2. Nat Rev Cancer. 2024. PMID: 39223250 Review.
8,679 results